Johnson & Johnson is “leaning” toward spinning out the hips-and-knees business that the company has been looking to hive off, Chief Financial Officer Joseph Wolk said. The move reflects ongoing strategic review of the medical device segment as J&J evaluates options to unlock value. Spinning out the unit could allow focused investment and clearer market positioning for the orthopedics business.
Wolk’s comments indicate the decision is not final but represents a significant step toward potential separation. Investors have long anticipated such a move amid pressure to streamline J&J’s diversified healthcare portfolio.
Source: Wall Street Journal US Business · Summarized by HeadlinesBriefing